AbbVie
ABBV
2,677 hedge funds and large institutions have $133B invested in AbbVie in 2021 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 1,281 increasing their positions, 904 reducing their positions, and 69 closing their positions.
133% more first-time investments, than exits
New positions opened: 161 | Existing positions closed: 69
42% more repeat investments, than reductions
Existing positions increased: 1,281 | Existing positions reduced: 904
2% more funds holding
Funds holding: 2,615 → 2,677 (+62)
4% more capital invested
Capital invested by funds: $128B → $133B (+$4.73B)
1% more funds holding in top 10
Funds holding in top 10: 138 → 139 (+1)
0.35% less ownership
Funds ownership: 67.41% → 67.05% (-0.35%)
3% less call options, than puts
Call options by funds: $2.28B | Put options by funds: $2.36B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$830M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$372M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$312M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$268M |
| 5 |
JP Morgan Chase
New York
|
+$146M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$453M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$362M |
| 3 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$350M |
| 4 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$264M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$226M |
ABBV Hedge Fund Activity: Q2 2021 in Review
2,677 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2021, worth a combined $133B — up 3.7% from $128B a quarter earlier.
Buyers outnumbered sellers: 161 funds opened new ABBV positions and 69 closed out — a net gain of 92 holders — while 1,281 added to existing stakes and 904 trimmed.
The largest buyer was Franklin Resources, adding an estimated $830M. The largest seller was BlackRock, cutting an estimated $453M.
- 2,677 institutional investors held AbbVie (ABBV) as of Q2 2021, up from 2,615 in Q1 2021.
- Funds reported $133B of AbbVie stock for Q2 2021, up 3.7% quarter-over-quarter.
- 161 funds opened new AbbVie positions in Q2 2021 and 69 closed out, a net change of +92 holders.
- The largest AbbVie buyer in Q2 2021 was Franklin Resources, an estimated $830M added.
- The largest AbbVie seller in Q2 2021 was BlackRock, an estimated $453M sold.
Based on aggregated 13F filings for Q2 2021.